Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-01-08

Clinical Trial Update: Epidural Clonidine for Postoperative Hyperalgesia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating epidural clonidine for postoperative hyperalgesia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Postoperative Hyperalgesia | Phase 3 | Status: WITHDRAWN